Objective To determine the health‐care preferences of people with Multiple Sclerosis (MS).
Design Cross‐sectional survey using a postal questionnaire comprising standardized …

This chapter concerns the measurement of health outcomes in multiple sclerosis (MS). The
first section outlines what outcome measurement is, why it is important, why it has become …

Abstract Purpose The Leeds Multiple Sclerosis Quality of Life (LMSQOL) scale was
designed as an 8-item, unidimensional disease-targeted measure of quality of life (QOL) …

Objective: To describe a holistic and comprehensive approach to the assessment of
sufferer's perceptio ns of health-related quality of life (HRQ oL) in a cohort of multiple …

Background Multiple sclerosis (MS) is a progressive autoimmune disease of the central
nervous system. Both the physical and mental burden of MS affect patients' health-related …

Background: The symptoms that have the largest impact on health-related quality of life
(HRQoL) in people with multiple sclerosis (MS) may vary by MS phenotype (relapsing …

Background There is increasing emphasis on using patient-reported outcomes (PROs) to
complement traditional clinical outcomes in medical research, including in multiple sclerosis …

Introduction. Health state valuation is a key input in many economic evaluations that inform
resource allocation across competing healthcare interventions. Empirical evidence has …

The need for measures of health-related quality of life (HRQOL) for clinical effectiveness
research and for quality of care research, particularly for chronic diseases, is increasingly …

Background: Evidence on the progress of disease severity in Multiple Sclerosis (MS) is
generally limited in scope. Objectives: To examine the course of a broad spectrum of MS …